OncoSec Medical (OTCQB:ONCS) is developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers, which is designed to significantly improve patient treatment outcomes compared to surgery and other treatment alternatives. The company’s core technology is based upon its proprietary electroporation OncoSec Medical System (OMS), which is used to deliver engineered DNA plasmid constructs that encode a specific cytokine. For more information visit the company’s Web site at www.oncosec.com

Marcum offers an extensive range of professional services and a high degree of specialization. In addition to traditional accounting, assurance, and tax, including domestic and international tax planning and preparation, the firm’s professional services include mergers and acquisition planning, family office services, forensic accounting, and litigation support. For more information on Marcum, visit www.marcumllp.com

Let us hear your thoughts below: